227 related articles for article (PubMed ID: 15019033)
1. Automated high throughput ADME assays for metabolic stability and cytochrome P450 inhibition profiling of combinatorial libraries.
Jenkins KM; Angeles R; Quintos MT; Xu R; Kassel DB; Rourick RA
J Pharm Biomed Anal; 2004 Mar; 34(5):989-1004. PubMed ID: 15019033
[TBL] [Abstract][Full Text] [Related]
2. In vitro ADME profiling using high-throughput rapidfire mass spectrometry: cytochrome p450 inhibition and metabolic stability assays.
Wu X; Wang J; Tan L; Bui J; Gjerstad E; McMillan K; Zhang W
J Biomol Screen; 2012 Jul; 17(6):761-72. PubMed ID: 22460176
[TBL] [Abstract][Full Text] [Related]
3. A high-throughput bioanalytical platform using automated infusion for tandem mass spectrometric method optimization and its application in a metabolic stability screen.
Kieltyka K; Zhang J; Li S; Vath M; Baglieri C; Ferraro C; Zvyaga TA; Drexler DM; Weller HN; Shou WZ
Rapid Commun Mass Spectrom; 2009 Jun; 23(11):1579-91. PubMed ID: 19399765
[TBL] [Abstract][Full Text] [Related]
4. Use of stable isotope labeled probes to facilitate liquid chromatography/mass spectrometry based high-throughput screening of time-dependent CYP inhibitors.
Dasgupta M; Tang W; Caldwell GW; Yan Z
Rapid Commun Mass Spectrom; 2010 Aug; 24(15):2177-85. PubMed ID: 20583325
[TBL] [Abstract][Full Text] [Related]
5. High-throughput cytochrome p450 inhibition assays by ultrafast gradient liquid chromatography with tandem mass spectrometry using monolithic columns.
Peng SX; Barbone AG; Ritchie DM
Rapid Commun Mass Spectrom; 2003; 17(6):509-18. PubMed ID: 12621611
[TBL] [Abstract][Full Text] [Related]
6. A novel incubation direct injection LC/MS/MS technique for in vitro drug metabolism screening studies involving the CYP 2D6 and the CYP 3A4 isozymes.
Bhoopathy S; Xin B; Unger SE; Karnes HT
J Pharm Biomed Anal; 2005 Apr; 37(4):739-49. PubMed ID: 15797796
[TBL] [Abstract][Full Text] [Related]
7. High-throughput cytochrome P450 inhibition assays using laser diode thermal desorption-atmospheric pressure chemical ionization-tandem mass spectrometry.
Wu J; Hughes CS; Picard P; Letarte S; Gaudreault M; Lévesque JF; Nicoll-Griffith DA; Bateman KP
Anal Chem; 2007 Jun; 79(12):4657-65. PubMed ID: 17497828
[TBL] [Abstract][Full Text] [Related]
8. A high throughput metabolic stability screening workflow with automated assessment of data quality in pharmaceutical industry.
Xu R; Manuel M; Cramlett J; Kassel DB
J Chromatogr A; 2010 Mar; 1217(10):1616-25. PubMed ID: 20132940
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of fluorescence- and mass spectrometry-based CYP inhibition assays for use in drug discovery.
Bell L; Bickford S; Nguyen PH; Wang J; He T; Zhang B; Friche Y; Zimmerlin A; Urban L; Bojanic D
J Biomol Screen; 2008 Jun; 13(5):343-53. PubMed ID: 18474896
[TBL] [Abstract][Full Text] [Related]
10. A high-throughput method for enzyme kinetic studies.
Saraswat LD; Caserta KA; Laws K; Wei D; Jones SS; Adedoyin A
J Biomol Screen; 2003 Oct; 8(5):544-54. PubMed ID: 14567781
[TBL] [Abstract][Full Text] [Related]
11. Rapid determination of six metabolites from multiple cytochrome P450 probe substrates in human liver microsome by liquid chromatography/mass spectrometry: application to high-throughput inhibition screening of terpenoids.
He F; Bi HC; Xie ZY; Zuo Z; Li JK; Li X; Zhao LZ; Chen X; Huang M
Rapid Commun Mass Spectrom; 2007; 21(5):635-43. PubMed ID: 17279482
[TBL] [Abstract][Full Text] [Related]
12. Multiple P450 substrates in a single run: rapid and comprehensive in vitro interaction assay.
Turpeinen M; Uusitalo J; Jalonen J; Pelkonen O
Eur J Pharm Sci; 2005 Jan; 24(1):123-32. PubMed ID: 15626586
[TBL] [Abstract][Full Text] [Related]
13. Application of a rapid and integrated analysis system (RIAS) as a high-throughput processing tool for in vitro ADME samples by liquid chromatography/tandem mass spectrometry.
Luippold AH; Arnhold T; Jörg W; Krüger B; Süssmuth RD
J Biomol Screen; 2011 Mar; 16(3):370-7. PubMed ID: 21335598
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of laser diode thermal desorption (LDTD) coupled with tandem mass spectrometry (MS/MS) for support of in vitro drug discovery assays: increasing scope, robustness and throughput of the LDTD technique for use with chemically diverse compound libraries.
Beattie I; Smith A; Weston DJ; White P; Szwandt S; Sealey L
J Pharm Biomed Anal; 2012 Feb; 59():18-28. PubMed ID: 22071442
[TBL] [Abstract][Full Text] [Related]
15. High-throughput, 384-well, LC-MS/MS CYP inhibition assay using automation, cassette-analysis technique, and streamlined data analysis.
Halladay JS; Delarosa EM; Tran D; Wang L; Wong S; Khojasteh SC
Drug Metab Lett; 2011 Aug; 5(3):220-30. PubMed ID: 21867481
[TBL] [Abstract][Full Text] [Related]
16. Validated assays for human cytochrome P450 activities.
Walsky RL; Obach RS
Drug Metab Dispos; 2004 Jun; 32(6):647-60. PubMed ID: 15155557
[TBL] [Abstract][Full Text] [Related]
17. Creation of a P450 array toward high-throughput analysis.
Sakai-Kato K; Kato M; Homma H; Toyo'oka T; Utsunomiya-Tate N
Anal Chem; 2005 Nov; 77(21):7080-3. PubMed ID: 16255613
[TBL] [Abstract][Full Text] [Related]
18. Analytical approaches to determine cytochrome P450 inhibitory potential of new chemical entities in drug discovery.
Smith D; Sadagopan N; Zientek M; Reddy A; Cohen L
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):455-63. PubMed ID: 17270503
[TBL] [Abstract][Full Text] [Related]
19. Utility of a column-switching LC/MS/MS method in cytochrome P450 inhibition assays using human liver microsomes.
Behera D; Pattem R; Kumar MS; Gudi GS
Drug Metabol Drug Interact; 2013; 28(3):177-85. PubMed ID: 23729559
[TBL] [Abstract][Full Text] [Related]
20. Sub one minute inhibition assays for the major cytochrome P450 enzymes utilizing ultra-performance liquid chromatography/tandem mass spectrometry.
Rainville PD; Wheaton JP; Alden PG; Plumb RS
Rapid Commun Mass Spectrom; 2008 May; 22(9):1345-50. PubMed ID: 18381621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
